Hyperparathyroidism Dialysis Patient Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Hyperparathyroidism Dialysis Patient
For individuals undergoing dialysis, managing secondary hyperparathyroidism is a significant health challenge. This condition, where overactive parathyroid glands cause an imbalance in calcium and phosphorus, often requires ongoing medication. The cost of these essential prescriptions can add up, but with TheDrugClub, you can access substantial savings, making your vital treatment more affordable.
Living with chronic kidney disease (CKD) and undergoing dialysis presents unique health challenges, and one common complication is secondary hyperparathyroidism. This condition arises when your parathyroid glands, four small glands in your neck, become overactive in response to the kidney's inability to properly filter waste and regulate mineral levels.
Normally, healthy kidneys convert vitamin D into its active form, which helps the body absorb calcium and signals the parathyroid glands to produce less parathyroid hormone (PTH). In CKD, the kidneys can't activate vitamin D, leading to low calcium levels and high phosphorus levels. In an attempt to correct this, the parathyroid glands work overtime, continuously releasing PTH, which can pull calcium from your bones, making them weak and brittle. Untreated, secondary hyperparathyroidism can lead to severe bone disease, calcification of blood vessels, and an increased risk of cardiovascular problems.
Managing secondary hyperparathyroidism often involves a multi-pronged approach. Your doctor may recommend dietary modifications, such as limiting phosphorus intake. Medications are typically central to treatment. These can include phosphate binders (like sevelamer or lanthanum) to reduce phosphorus absorption from food, active vitamin D analogs (such as calcitriol, paricalcitol, or doxercalciferol) to help regulate calcium and phosphorus, and calcimimetics (like cinacalcet or etelcalcetide) to trick the parathyroid glands into reducing PTH production. In some severe cases, a parathyroidectomy (surgical removal of the glands) might be necessary.
The ongoing nature of these treatments means recurring prescription costs, which can become a significant financial burden. That's where TheDrugClub steps in. For a low monthly membership fee—with a Drug Club membership—you can unlock substantial savings on many commonly prescribed medications for hyperparathyroidism, including phosphate binders, vitamin D analogs, and calcimimetics. This isn't insurance; it's a straightforward discount program. There are no deductibles
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.